Topic Review
Microbiome Influence on Atopic Dermatitis
It is acknowledged that humans have a diverse and abundant microbial community known as the human microbiome. Nevertheless, the comprehension of the numerous functions these microorganisms have in human health is still in its early stages. Microorganisms belonging to the human microbiome typically coexist with their host, but in certain situations, they can lead to diseases. They are found in several areas of the human body in healthy individuals. The microbiome is highly diverse, and its composition varies depending on the body site. 
  • 241
  • 27 Sep 2023
Topic Review
Pathogenesis of Galli–Galli Disease
Galli–Galli disease (GGD) is a rare genodermatosis that exhibits autosomal dominant inheritance with variable penetrance. GGD typically manifests with erythematous macules, papules, and reticulate hyperpigmentation in flexural areas. A distinct atypical variant exists, which features brown macules predominantly on the trunk, lower limbs, and extremities, with a notable absence of the hallmark reticulated hyperpigmentation in flexural areas.
  • 237
  • 26 Feb 2024
Topic Review
Psychotropic Medications and Dermatological Side Effects
Psychotropic medications, commonly prescribed for psychiatric disorders, can have underappreciated dermatological side effects. Adverse reactions (ADRs) to these medications are a leading cause of discontinuations and therefore can lead to poor compliance. The diagnosis of drug-induced dermatological reactions is a significant challenge due to factors such as multifactorial aetiology and complex presentation.
  • 236
  • 18 Jan 2024
Topic Review
The Spectrum of Dermatitis and Eczema
Dermatitis (eczema) is a noninfectious inflammation of the epidermis and dermis that manifests itself through an array of efflorescences, including erythema, edema, inflammatory infiltrate, papules, vesicles, scales, serous crusts and lichenification. Depending on the stage and intensity of the disease, these skin changes may emerge in various constellations simultaneously or may evolve from one another. They are typically accompanied by the subjective sensation of itch (pruritus), pain or stinging or burning sensations of various intensities. The histological picture of dermatitis/eczema includes spongiosis, acanthosis, parakeratosis or hyperkeratosis in the epidermis, in addition to lymphocytic and granulocytic infiltration of the upper dermis and epidermis. The term “dermatitis” means literally “inflammation of the skin”; however, its use in dermatology is restricted to a subgroup of non-infectious inflammatory skin diseases with similar clinical appearances, creating the spectrum of dermatitis and eczema (SoDE). Therefore, tinea (a fungal infection of the skin), psoriasis or inflammatory acne will not be referred to as “dermatitis” even though inflammation of the skin is their inherent feature. Depending on the country and dermatology school, the term “eczema” could refer to acute dermatitis (e.g., in the USA) or chronic dermatitis (e.g., in Germany). Moreover, some scholars maintain that “eczema” means dermatitis with a known cause, while “dermatitis” would suggest that there is no definite diagnosis yet. Finally, the term “eczema” is used by some scholars as a synonym of “atopic dermatitis” (AD), which should be strongly discouraged as misleading and confusing. In light of these contradictions, it seems most reasonable to consider the terms “dermatitis” and “eczema” synonyms.
  • 234
  • 26 Jul 2023
Topic Review
Extracellular Vesicles for Non-Melanoma Skin Cancer
Standard non-melanoma skin cancer (NMSC) treatment involves surgery, recently combined with chemotherapy or immunotherapy in cases of advanced tumors. EVs, including exosomes, are integral to carcinogenesis, and are found in NMSC releasing mediators impacting tumor progression. Nevertheless, the precise intercellular signaling role of NMSC-derived EVs remains unclear. 
  • 233
  • 18 Mar 2024
Topic Review
Janus Kinase Inhibitors in Treatment of Dermatologic Conditions
Janus kinase inhibitors, also known as JAK inhibitors, JAKinibs or JAKi, are a new group of disease-modifying drugs. They work by inhibiting enzymes involved in the transmission of information from receptors located in the cell membrane to the cell interior, specifically to the cell nucleus, thus disrupting the JAK-STAT pathway. This pathway plays a role in key cellular processes such as the immune response and cell growth. This feature is used in the treatment of patients with rheumatological, gastroenterological and hematological diseases. It has been discovered that JAK-STAT pathway inhibitors also show therapeutic potential against dermatological diseases such as atopic dermatitis, psoriasis, alopecia areata and acquired vitiligo. Studies are underway to use them in the treatment of several other dermatoses. Janus kinase inhibitors represent a promising class of drugs for the treatment of skin diseases refractory to conventional therapy.
  • 233
  • 19 Dec 2023
Topic Review
Preferentially Expressed Antigen in Melanoma in Skin Cancer
Preferentially Expressed Antigen in Melanoma (PRAME), a member of the cancer/testis antigen family, is central to the field of skin cancer diagnostics and therapeutics. As a nuclear receptor and transcriptional regulator, PRAME plays a critical role in inhibiting retinoic acid signalling, which is essential for cell differentiation and proliferation. Its aberrant overexpression in various malignancies, particularly cutaneous melanoma, is associated with more aggressive tumour phenotypes, positioning PRAME as both a diagnostic and prognostic marker. In melanoma, PRAME is typically highly expressed, in contrast to its weak or absent expression in benign nevi, thereby improving the accuracy of differential diagnoses. The diagnostic value of PRAME extends to various lesions. It is significantly expressed in uveal melanoma, correlating to an increased risk of metastasis. In acral melanomas, especially those with histopathological ambiguity, PRAME helps to improve diagnostic accuracy.
  • 232
  • 29 Jan 2024
Topic Review
Eccrine Porocarcinoma
Eccrine porocarcinoma (EPC) constitutes a rare malignant adnexal tumor, which accounts for about 0.005–0.01% of all cutaneous malignancies. It may develop de novo or arise from an eccrine poroma, after a latency period of years or even decades.
  • 229
  • 27 Apr 2023
Topic Review
Stem Cells in Wound Healing
Wound healing is an intricate process involving coordinated interactions among inflammatory cells, skin fibroblasts, keratinocytes, and endothelial cells. Successful tissue repair hinges on controlled inflammation, angiogenesis, and remodeling facilitated by the exchange of cytokines and growth factors. Comorbid conditions can disrupt this process, leading to significant morbidity and mortality. Stem cell therapy has emerged as a promising strategy for enhancing wound healing, utilizing cells from diverse sources such as endothelial progenitor cells, bone marrow, adipose tissue, dermal, and inducible pluripotent stem cells.
  • 228
  • 14 Mar 2024
Topic Review
Gut Microbiome and Microbial Dysbiosis in Dermatologic Conditions
Dermatoses are an increasingly common problem, particularly in developed countries. The causes of this phenomenon include genetic factors and environmental elements. More and more scientific reports suggest that the gut microbiome, more specifically its dysbiosis, also plays an important role in the induction and progression of diseases, including dermatological diseases. The gut microbiome is recognised as the largest endocrine organ, and has a key function in maintaining human homeostasis.
  • 225
  • 29 Feb 2024
  • Page
  • of
  • 34
ScholarVision Creations